Larvol Delta - Acurx-Announces-Publication-of-Positive-Results-from-an-InSilico-Study-Predicting-the-MicrobiomeRestorative-Potential-of-Ibezapolstat-in-the-Treatment-of-CDI

ibezapolstat (ACX-362E) - Acurx Pharma

https://www.newswire.ca/news-releases/acurx-announces-publication-of-positive-results-from-an-in-silico-study-predicting-the-microbiome-restorative-potential-of-ibezapolstat-in-the-treatment-of-cdi-824255231.html

Feb 24, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next